Unknown

Dataset Information

0

Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal data.


ABSTRACT: UNLABELLED:Existing predictive models of risk of disease progression in chronic hepatitis C have limited accuracy. The aim of this study was to improve upon existing models by applying novel statistical methods that incorporate longitudinal data. Patients in the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis trial were analyzed. Outcomes of interest were (1) fibrosis progression (increase of two or more Ishak stages) and (2) liver-related clinical outcomes (liver-related death, hepatic decompensation, hepatocellular carcinoma, liver transplant, or increase in Child-Turcotte-Pugh score to ?7). Predictors included longitudinal clinical, laboratory, and histologic data. Models were constructed using logistic regression and two machine learning methods (random forest and boosting) to predict an outcome in the next 12 months. The control arm was used as the training data set (n?=?349 clinical, n?=?184 fibrosis) and the interferon arm, for internal validation. The area under the receiver operating characteristic curve for longitudinal models of fibrosis progression was 0.78 (95% confidence interval [CI] 0.74-0.83) using logistic regression, 0.79 (95% CI 0.77-0.81) using random forest, and 0.79 (95% CI 0.77-0.82) using boosting. The area under the receiver operating characteristic curve for longitudinal models of clinical progression was 0.79 (95% CI 0.77-0.82) using logistic regression, 0.86 (95% CI 0.85-0.87) using random forest, and 0.84 (95% CI 0.82-0.86) using boosting. Longitudinal models outperformed baseline models for both outcomes (P?

SUBMITTER: Konerman MA 

PROVIDER: S-EPMC4480773 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal data.

Konerman Monica A MA   Zhang Yiwei Y   Zhu Ji J   Higgins Peter D R PD   Lok Anna S F AS   Waljee Akbar K AK  

Hepatology (Baltimore, Md.) 20150320 6


<h4>Unlabelled</h4>Existing predictive models of risk of disease progression in chronic hepatitis C have limited accuracy. The aim of this study was to improve upon existing models by applying novel statistical methods that incorporate longitudinal data. Patients in the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis trial were analyzed. Outcomes of interest were (1) fibrosis progression (increase of two or more Ishak stages) and (2) liver-related clinical outcomes (liver-related dea  ...[more]

Similar Datasets

| S-EPMC10494315 | biostudies-literature
| S-EPMC7179850 | biostudies-literature
| S-EPMC6502011 | biostudies-literature
| S-EPMC6319275 | biostudies-literature
| S-EPMC7077138 | biostudies-literature
| S-EPMC4120150 | biostudies-literature
| S-EPMC4167918 | biostudies-literature
| S-EPMC5963469 | biostudies-literature
| S-EPMC2582333 | biostudies-literature
| S-EPMC10118194 | biostudies-literature